The Musella Foundation For Brain Tumor Research & Information, Inc awarded a $10,000 brain tumor research grant today to Dr Madon Kwatra of Duke University for project:  Heterogeneity of EGFRvIII-positive glioblastoma and their sensitivity to AZD9291 (Osimertinib).

 

 This is an important project because the drug being studied is approved for Lung Cancer. so if they find it useful for glioblastomas, it can immediately be used off label!